Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 649 | Longs Won 325/633 51% | Profit Factor 0.35 |
| Profitability | Shorts Won 4/16 25% | Standard Deviation $2,622.33 |
| Average Win $153.21 | Best Trade (Aug 07) $8,234.58 | Sharpe Ratio -81.49 |
| Average Loss -$444.3 | Worst Trade (Dec 28) -$61,475.83 | Z-Score -6.2 (100%) |
| Commissions $0 | Avg. Trade Length 2m 3d | Expectancy -$141.01 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | - | - | - | - | - | - | - | - | - | - |
| Consecutive Losing Trades | 19 | 17 | 15 | 13 | 11 | 10 | 8 | 6 | 4 | 2 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
BCRX BioCryst Pharmaceuticals Inc. | 940.44 | $9,404.44 | $8,482.81 | - | -$921.63 | -9.8% | 0.0 |